Document Detail


Agreement between self-reported use of in vitro fertilization or ovulation induction, and medical insurance claims in Australian women aged 28-36 years.
MedLine Citation:
PMID:  22740497     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
STUDY QUESTION: What is the self-reported use of in vitro fertilization (IVF) and ovulation induction (OI) in comparison with insurance claims by Australian women aged 28-36 years?
SUMMARY ANSWER: The self-reported use of IVF is quite likely to be valid; however, the use of OI is less well reported.
WHAT IS KNOWN AND WHAT THIS PAPER ADDS: Population-based research often relies on the self-reported use of IVF and OI because access to medical records can be difficult and the data need to include sufficient personal identifying information for linkage to other data sources. There have been few attempts to explore the reliability of the self-reported use of IVF and OI using the linkage to medical insurance claims for either treatment.
STUDY DESIGN: This prospective, population-based, longitudinal study included the cohort of women born during 1973-1978 and participating in the Australian Longitudinal Study on Women's Health (ALSWH) (n = 14247). From 1996 to 2009, participants were surveyed up to five times.
PARTICIPANTS AND SETTING: Participants self-reported their use of IVF or OI in two mailed surveys when aged 28-33 and 31-36 years (n = 7280), respectively. This study links self-report survey responses and claims for treatment or medication from the universal national health insurance scheme (i.e. Medicare Australia).
MAIN RESULTS AND THE ROLE OF CHANCE: Comparisons between self-reports and claims data were undertaken for all women consenting to the linkage (n = 3375). The self-reported use of IVF was compared with claims for OI for IVF (Kappa, K = 0.83), oocyte collection (K = 0.82), sperm preparation (K = 0.83), intracytoplasmic sperm injection (K = 0.40), fresh embryo transfers (K = 0.82), frozen embryo transfers (K = 0.64) and OI for IVF medication (K = 0.17). The self-reported use of OI was compared with ovulation monitoring (K = 0.52) and OI medication (K = 0.71).
BIAS, CONFOUNDING AND OTHER REASONS FOR CAUTION: There is a possibility of selection bias due to the inclusion criteria for participants in this study: (1) completion of the last two surveys in a series of five and (2) consent to the linkage of their responses with Medicare data.
GENERALIZABILITY TO OTHER POPULATIONS: The results are relevant to questionnaire-based research studies with infertile women in developed countries.
Authors:
Danielle Herbert; Jayne Lucke; Annette Dobson
Related Documents :
21062797 - "an object of vulgar curiosity": legitimizing medical hypnosis in imperial germany.
21138797 - Low-power ultrawideband wireless telemetry transceiver for medical sensor applications.
21513087 - Death and doctor hornbook by robert burns: a view from medical history.
21356097 - The role of the user within the medical device design and development process: medical ...
20663767 - One step forward, two steps back? the gmc, the common law and 'informed' consent.
18775367 - Pharmacotherapy of irritability in pervasive developmental disorders.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2012-06-26
Journal Detail:
Title:  Human reproduction (Oxford, England)     Volume:  27     ISSN:  1460-2350     ISO Abbreviation:  Hum. Reprod.     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-08-10     Completed Date:  2013-01-11     Revised Date:  2013-11-06    
Medline Journal Info:
Nlm Unique ID:  8701199     Medline TA:  Hum Reprod     Country:  England    
Other Details:
Languages:  eng     Pagination:  2823-8     Citation Subset:  IM    
Affiliation:
The University of Queensland School of Population Health, Public Health Building, Herston Rd, Brisbane, Queensland 4006, Australia. d.herbert@sph.uq.edu.au
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Australia
Female
Fertilization in Vitro / economics,  methods*
Humans
Infertility, Female / economics,  therapy*
Insurance Claim Review
Insurance, Health
Longitudinal Studies
Models, Statistical
Ovulation Induction / economics,  methods*
Prospective Studies
Questionnaires
Reproducibility of Results
Self Report

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The impact of pronuclei morphology and dynamicity on live birth outcome after time-lapse culture.
Next Document:  Chromosomal abnormalities in azoospermic and non-azoospermic infertile men: numbers needed to be scr...